Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 827 across all filing types
Latest filing 2026-06-05 Capital/Financing Update
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue - Attachment: Lifecare ASA- Last day of trading in Warrants Series 2 issued in connection with the Rig
Capital/Financing Update Classification · 80% confidence The document is a press release detailing the last trading day of warrant Series 2 issued in connection with a rights issue and outlining the exercise period, dilution risk, and trading suspension. This concerns a financing activity and capital structure update rather than a regulatory filing, financial report, or shareholder vote. Therefore, it falls under Capital/Financing Update (CAP).
2026-06-05 English
Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue
Capital/Financing Update Classification · 90% confidence The document is a statutory announcement under the Norwegian Securities Trading Act describing the timeline and trading suspension for Warrants Series 2 issued in connection with a partially underwritten rights issue (a financing transaction). It provides an update on the exercise period and trading arrangements tied to the company’s capital‐raising. This aligns with a Capital/Financing Update rather than a share-issue notice or other category.
2026-06-05 English
Lifecare ASA: Mandatory notification of trade - Attachment: 260603 PDMR Attachment Morten Foros Krohnstad.pdf
Director's Dealing Classification · 98% confidence The document is a notification of an insider trade by the Chair of the Board, detailing the purchase of warrants (ISIN NO0013709204), including price, volume, date, and place of transaction. This fits the definition of Director’s Dealing (insider transactions) rather than a broader report or announcement category.
2026-06-03 English
Lifecare ASA: Mandatory notification of trade - Attachment: Lifecare ASA- Mandatory notification of trade.pdf
Director's Dealing Classification · 92% confidence The document is a press release titled “Mandatory Notification of Trade” by Lifecare ASA, detailing an insider transaction where the Chair of the Board has purchased warrants. It cites Securities Trading Act requirements and provides an attached insider notification form. This is a report of a personal share/warrant transaction by a company director, matching the definition of Director’s Dealing (insider trades).
2026-06-03 English
Lifecare ASA: Mandatory notification of trade
Director's Dealing Classification · 99% confidence The document is a mandatory notification of an insider’s (Chair of the Board) purchase of company warrants, referencing the Securities Trading Act and MAR. This clearly reports a personal share transaction by a director (insider trade). Therefore, it is a Director's Dealing filing.
2026-06-03 English
Lifecare ASA: Commencement of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue - Attachment: Lifecare ASA- Commencement of the Exercise Period for Warrants Series 2
Capital/Financing Update Classification · 90% confidence The document is a press release announcing the commencement of the exercise period for warrants issued in connection with a rights issue, detailing exercise procedures, payment dates, and listing of new shares. This is an update on the company’s fundraising and capital structure transaction. Therefore, it falls under Capital/Financing Update (CAP).
2026-06-01 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.